| Date Filed | Type | Description |
| 08/11/2023 |
4
| Lang Matthew (Chief Business Officer) has filed a Form 4 on Lyell Immunopharma, Inc.|
Txns:
| Granted 2,250,000 options to buy
@ $2.31, valued at
$5.2M
|
|
| 07/20/2023 |
3
| Lang Matthew (Chief Business Officer) has filed a Form 3 on Lyell Immunopharma, Inc. |
| 03/10/2023 |
4
| Lang Matthew (General Counsel & Corp. Secy.) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Disposed/sold 113,145 shares
@ $0
Disposed/sold 241,158 shares
@ $0
Disposed/sold 220,000 options to buy
@ $7.78, valued at
$1.7M
Disposed/sold 87,050 options to buy
@ $7.78, valued at
$677.2k
Disposed/sold 152,110 options to buy
@ $7.78, valued at
$1.2M
Disposed/sold 170,396 options to buy
@ $8.08, valued at
$1.4M
Disposed/sold 90,310 options to buy
@ $17.88, valued at
$1.6M
Disposed/sold 111,111 rights
@ $0 |
|
| 01/20/2023 |
4
| Lang Matthew (General Counsel & Corp. Secy.) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Sold 1,272 shares
@ $26.89, valued at
$34.2k
|
|
| 01/05/2023 |
4
| Lang Matthew (General Counsel & Corp. Secy.) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Sold 2,779 shares
@ $26.9, valued at
$74.8k
|
|
| 10/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/06/2022 |
4
| Lang Matthew (General Counsel & Corp. Secy.) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Sold 3,679 shares
@ $24.4, valued at
$89.8k
|
|
| 08/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/21/2022 |
4
| Lang Matthew (General Counsel & Corp. Secy.) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Sold 8,002 shares
@ $10.45, valued at
$83.6k
|
|
| 04/19/2022 |
4
| Lang Matthew (General Counsel & Corp. Secy.) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Granted 111,111 shares
@ $0 |
|
| 04/07/2022 |
4
| Lang Matthew (General Counsel & Corp. Secy.) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Sold 2,436 shares
@ $13.78, valued at
$33.6k
|
|
| 01/06/2022 |
4
| Lang Matthew (General Counsel & Corp. Secy.) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Sold 4,475 shares
@ $16.27, valued at
$72.8k
|
|
| 10/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/22/2020 |
4
| Lang Matthew (General Counsel & Corp. Secy.) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Sold 9,700 shares
@ $25.3797, valued at
$246.2k
Sold 300 shares
@ $26.2367, valued at
$7.9k
Exercised 10,000 options to buy
@ $7.78, valued at
$77.8k
|
|
| 12/11/2020 |
4
| Lang Matthew (General Counsel & Corp. Secy.) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Sold 600 shares
@ $25.0817, valued at
$15k
Sold 19,400 shares
@ $25.195, valued at
$488.8k
Exercised 600 options to buy
@ $7.78, valued at
$4.7k
Exercised 19,400 options to buy
@ $7.78, valued at
$150.9k
|
|
| 09/02/2020 |
4
| Lang Matthew (General Counsel & Corp. Secy.) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Sold 26,700 shares
@ $20.048, valued at
$535.3k
Exercised 26,700 options to buy
@ $7.78, valued at
$207.7k
|
|
| 08/28/2020 |
4
| Lang Matthew (General Counsel & Corp. Secy.) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Sold 100 shares
@ $20, valued at
$2k
Sold 2,600 shares
@ $20.02, valued at
$52.1k
Exercised 100 options to buy
@ $7.78, valued at
$778
Exercised 2,600 options to buy
@ $7.78, valued at
$20.2k
|
|
| 08/21/2020 |
4
| Lang Matthew (General Counsel & Corp. Secy.) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Sold 600 shares
@ $20, valued at
$12k
Exercised 600 options to buy
@ $7.78, valued at
$4.7k
|
|
| 04/07/2020 |
4
| Lang Matthew (General Counsel & Corp. Secy.) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Granted 111,268 shares
@ $0
Granted 170,396 options to buy
@ $8.08, valued at
$1.4M
|
|
| 12/30/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/27/2019 |
4
| Lang Matthew (General Counsel & Corp. Secy.) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Granted 53,615 shares
@ $0
Disposed/sold 310,000 options to buy
@ $11.3, valued at
$3.5M
Granted 310,000 options to buy
@ $7.78, valued at
$2.4M
Disposed/sold 87,050 options to buy
@ $21.87, valued at
$1.9M
Granted 87,050 options to buy
@ $7.78, valued at
$677.2k
Disposed/sold 152,110 options to buy
@ $24.44, valued at
$3.7M
Granted 152,110 options to buy
@ $7.78, valued at
$1.2M
|
|
| 04/09/2019 |
4
| Lang Matthew (General Counsel & Corp. Secy.) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Granted 152,110 options to buy
@ $24.44, valued at
$3.7M
|
|
| 04/18/2018 |
4
| Lang Matthew (General Counsel & Corp. Secy.) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Granted 87,050 options to buy
@ $21.87, valued at
$1.9M
|
|
| 07/18/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/18/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |